Volume 148, Issue 1, Pages (January 2018)

Slides:

Advertisements

Similar presentations

Nicoletta Colombo, Martin Gore

Advertisements

Volume 144, Issue 1, Pages (January 2017)

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung Sai-Hong.

Oncol Res Treat 2016;39: DOI: /

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.

Girma Tefera, MD, Charles W. Acher, MD, John R

Are patients willing to travel for better ovarian cancer care?

Volume 148, Issue 1, Pages (January 2018)

L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L

Volume 148, Issue 1, Pages (January 2018)

Volume 146, Issue 3, Pages (September 2017)

Volume 150, Issue 3, Pages (September 2018)

A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L

Vulvar intraepithelial neoplasia: Risk factors for recurrence

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Volume 144, Issue 2, Pages (February 2017)

Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis M. Proesmans, F. Vermeulen,

The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells

Volume 152, Issue 1, Pages (January 2019)

Volume 141, Issue 2, Pages (May 2016)

Karin J. C. Sanders, MD, Lizza E. Hendriks, MD, Esther G. C

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

Volume 151, Issue 1, Pages (October 2018)

Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei

Volume 148, Issue 1, Pages (January 2018)

Supportive care plans: Linking patient-reported outcomes to evidence-based supportive care across the cancer continuum E.E. Stevens, J.N. Bottsford-Miller,

Volume 145, Issue 2, Pages (May 2017)

Volume 142, Issue 3, Pages (September 2016)

National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence J. Chino, J.R. Foote,

Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer E.N. Prendergast,

Volume 151, Issue 1, Pages (October 2018)

K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani

Volume 152, Issue 1, Pages (January 2019)

Volume 143, Issue 2, Pages (November 2016)

Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base A. Melamed, J.T. Clemmer, N.L. Keating, J.D. Wright,

The origins of multidisciplinary cancer care

Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)

Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM) C. Popadiuk, A.J. Coldman,

Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.

I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,

Volume 77, Issue 2, Pages (January 2010)

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates N.A. Latif, E.M. Ko,

Volume 130, Issue 1, Pages (July 2013)

Volume 152, Issue 1, Pages (January 2019)

Volume 147, Issue 1, Pages (October 2017)

Volume 152, Issue 1, Pages (January 2019)

Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.

Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Volume 152, Issue 1, Pages (January 2019)

The complex interaction of cancer surgery, complications, and patient-reported outcomes: A single score is not enough K.M. Doll, E.L. Barber, J.T. Bensen,

Volume 142, Issue 2, Pages (August 2016)

Annika Idahl, Andrea Hermansson, Ann Lalos Gynecologic Oncology

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study

Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients? Filipa Tavares, MD Journal of Pain and Symptom.

Volume 147, Issue 3, Pages (December 2017)

Volume 152, Issue 1, Pages (January 2019)

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Volume 152, Issue 1, Pages (January 2019)

Volume 151, Issue 1, Pages (October 2018)

Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer M. Dandapani, B.L. Seagle, R. Samuelson,

Pulmonary Resection for Metastases from Colorectal Cancer

Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J

Volume 124, Issue 1, Pages (January 2012)

Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma? L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,

Volume 115, Issue 1, Pages (October 2009)

Volume 154, Issue 1, Pages (July 2019)

Presentation transcript:

Volume 148, Issue 1, Pages 19-27 (January 2018) Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence Miriam Champer, Yongmei Huang, June Y. Hou, Ana I. Tergas, William M. Burke, Grace Clarke Hillyer, Cande V. Ananth, Alfred I. Neugut, Dawn L. Hershman, Jason D. Wright Gynecologic Oncology Volume 148, Issue 1, Pages 19-27 (January 2018) DOI: 10.1016/j.ygyno.2017.11.008 Copyright © 2017 Terms and Conditions

Fig. 1 Flowchart for cohort selection. Gynecologic Oncology 2018 148, 19-27DOI: (10.1016/j.ygyno.2017.11.008) Copyright © 2017 Terms and Conditions

Fig. 2 Duration of platinum free interval between completion of adjuvant therapy and initiation of salvage therapy. Gynecologic Oncology 2018 148, 19-27DOI: (10.1016/j.ygyno.2017.11.008) Copyright © 2017 Terms and Conditions

Fig. 3 Kaplan-Meier curves of survival based on platinum free interval. Gynecologic Oncology 2018 148, 19-27DOI: (10.1016/j.ygyno.2017.11.008) Copyright © 2017 Terms and Conditions